Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholesterol-modifying drugs in COVID-19
Nathalie Schmidt, Peter A. C. Wing, Jane A. McKeating, et al.
Oxford Open Immunology (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The role of high cholesterol in age-related COVID19 lethality
Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 140
Dissecting lipid metabolism alterations in SARS-CoV-2
Ilaria Casari, Marcello Manfredi, Pat Metharom, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101092-101092
Open Access | Times Cited: 107
Coronavirus Infection and Cholesterol Metabolism
Jun Dai, Huan Wang, Ying Liao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 39
Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture
Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 37
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 6, pp. 101220-101220
Open Access | Times Cited: 49
Probing SARS-CoV-2 membrane binding peptide via single-molecule AFM-based force spectroscopy
Qingrong Zhang, Ricardo de Souza Rosa, Ankita Ray, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1743-1765
Open Access | Times Cited: 30
7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19
Imen Ghzaiel, Khouloud Sassi, Amira Zarrouk, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 212, pp. 105939-105939
Open Access | Times Cited: 29
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Wildeman Zapata, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 16
Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112095-112095
Open Access | Times Cited: 21
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Peter A. C. Wing, Nathalie Schmidt, Rory Peters, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011323-e1011323
Open Access | Times Cited: 8
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling
Emmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105066-105066
Open Access | Times Cited: 13
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry
Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 17
Inferring the Main Drivers of SARS‐CoV‐2 Global Transmissibility by Feature Selection Methods
Marko Djordjević, Igor Salom, Sofija Marković, et al.
GeoHealth (2021) Vol. 5, Iss. 9
Open Access | Times Cited: 15
Sleep and circadian rhythm disruption alters the lung transcriptome to predispose to viral infection
Lewis Taylor, Felix Von Lendenfeld, Anna Ashton, et al.
iScience (2022) Vol. 26, Iss. 2, pp. 105877-105877
Open Access | Times Cited: 10
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis
Dhanya R. Iyer, Janani Venkatraman, Émeline Tanguy, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Open Access | Times Cited: 5
Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces
Finlay A. McAlister, Ting Wang, Xuesong Wang, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 21
Open Access | Times Cited: 12
Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
Saravanan Sekaran, Suresh Kumar R Sekar
International Journal of Surgery (2023) Vol. 109, Iss. 1, pp. 60-61
Open Access | Times Cited: 4
Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications
Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 4, pp. 725-739
Open Access | Times Cited: 9
Covid and cholesterol (C&C): Something to worry about or much ado about nothing?
Heena Garg, Puneet Khanna
Trends in Anaesthesia and Critical Care (2020) Vol. 36, pp. 39-40
Open Access | Times Cited: 6
Defective interferon amplification and impaired host responses against influenza virus in obese mice
Pratibha Gaur, Mathias Riehn, Lisha Zha, et al.
Obesity (2021) Vol. 29, Iss. 8, pp. 1272-1278
Open Access | Times Cited: 6
Mass spectrometric approaches in discovering lipid biomarkers for COVID‐19 by lipidomics: Future challenges and perspectives
Siddabasave Gowda B. Gowda, Chandra Shekhar, Divyavani Gowda, et al.
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1041-1065
Closed Access | Times Cited: 2
Is Trikatu an ayurvedic formulation effective for the management of flu-like illness? A narrative review
Danish Javed, Ashish Dixit
Journal of Complementary and Integrative Medicine (2021) Vol. 19, Iss. 2, pp. 193-202
Closed Access | Times Cited: 5
Pemberdayaan Masyarakat dalam Penanggulangan COVID-19 pada Lansia dengan Komorbid Sindroma Metabolik di Sukoharjo Jawa Tengah
Sri Suwarni
Madaniya (2024) Vol. 5, Iss. 1, pp. 1-11
Open Access
Page 1 - Next Page

Scroll to top